News
03.12.24
ERC Consolidator Grants Awarded to Two SR-Tiget Researchers
Daniela Cesana and Alessio Cantore presented two projects, respectively to investigate the impact, safety and efficacy of gene therapy through the 'signatures' of circulating DNA and to investigate the biology of liver cells in order to exploit them in the field of gene therapy.
28.11.24
Gene therapy: target liver
At the San Raffaele-Telethon Institute in Milan, an innovative liver-directed gene transfer platform applicable to various metabolic diseases has been developed thanks to the efforts of the research group led by Alessio Cantore, together with the biotech company Genespire.
18.11.24
Mucopolysaccharidosis 6 and gene therapy: present and future
A study just published by TIGEM researchers shows how the efficacy of this experimental therapy is maintained over time, at the highest doses. Study coordinator Brunetti-Pierri reports on possible future developments
16.09.24
Naples, world's first gene therapy for a rare retinal disease
The surgery, performed at AOU Vanvitelli, was made possible by an innovative gene therapy platform developed by Pozzuoli's TIGEM that allows for large gene transfer.
05.09.24
ERC Funding to three young researchers from Fondazione Telethon Institutes
Fondazione Telethon has announced that the European Research Council, has awarded three researchers from Fondazione Telethon Institutes: Samuele Ferrari and Attya Omer from SR-TIGET and Ivana Trapani from TIGEM
10.07.24
Ilaria Villa new Managing Director of Fondazione Telethon
Fondazione Telethon Board of Directors chaired by Luca di Montezemolo appoints Ilaria Villa as new Managing Director.
15.04.24
Alberto Auricchio appointed as director at TIGEM
Alberto Auricchio, full professor of Medical Genetics at the Federico II University of Naples, is the new director of the Telethon Institute of genetics and Medicine
28.02.24
Fondazione Telethon announces commitment to make gene therapy for Wikott-Aldrich Syndrome available to patients
The announcement arrives on the eve of the 26th World Rare Disease Day
12.09.23
Fondazione Telethon and Orchard Therapeutics complete transfer of marketing authorization of Strimvelis for ADA-SCID in Europe
Following a positive opinion from the EMA, Fondazione Telethon will now be responsible for providing the gene therapy to eligible patients in the European Union.
